Acme Formulation is a leading provider of contract manufacturing and development services for oral solid and sterile dosage forms in the pharmaceutical industry. Established in 2005, Acme has evolved into a trusted partner and complete solution provider, offering niche segments such as oral hormones, sex hormones, levothyroxine, and general injectables. Acme operates three state-of-the-art manufacturing facilities in Northern India, employing over 2,500 professionals and producing 15 billion tablets, 5 billion capsules, and 42 million ampoules/vials annually.
Acme has been audited and approved by various international regulatory agencies, including USFDA, UK-MHRA, EU-GMP (Hungary), and ANVISA (Brazil). The company is also recognized by authorities in Nigeria, Ghana, Uganda, Kenya, Nepal, Cambodia, and several other countries. Acme's commitment to quality, innovation, and regulatory excellence ensures the delivery of high-quality pharmaceutical solutions to global markets.
Acme remains dedicated to building a sustainable future, focusing on delivering high-quality pharmaceutical solutions to global markets. The company's robust production capacity and international certifications make it a reliable partner for pharmaceutical companies worldwide.
| Ownership Private Company |
B2B professionals would contact Acme Formulation for its robust production capacity, international certifications, and commitment to quality and innovation. Acme's expertise in niche segments and global market reach make it an ideal partner for pharmaceutical companies seeking reliable contract manufacturing and development services.
Sales teams selling pharmaceutical manufacturing services, recruiters seeking roles in pharmaceutical manufacturing, and partners offering contract manufacturing and development services should reach out to Acme Formulation.
Companies that compete with or operate in similar markets to Acme Formulation:
Click on highlighted companies to view their profiles on Data Surfer.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with Acme Formulation